BackGenelink Overview

Genelink Research & Development

Research & Development expenses for GNLKQ.

Quarterly R&D Expenses

$27444.00
62.01% YoY

As of Sep 30, 2013

Annual R&D Expenses (TTM)

$167327.00
25.41% YoY

Trailing 12 months ending Sep 30, 2013

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)